Skip Navigation

News Videos

  • Watch brief explainer videos focusing on science, research, and advances in cancer, featuring Dana-Farber Cancer Institute doctors and researchers.

  • Breast Cancer Surgery and Impact on Quality of Life in Young Women
    New research released by Dana-Farber/Brigham and Women's Cancer Center shows more young women with breast cancer opting to have mastectomies even as many experience a persistent decline in their sexual and psychosocial well-being. The findings were just presented at the San Antonio Breast Cancer Symposium.

  • Improving Outcomes for Myeloid Cancers
    Improving outcomes for myeloid cancer patients who undergo stem cell transplantation is a focus of several studies presented by Dana-Farber Cancer Institute scientists at the American Society of Hematology Annual Meeting.

  • Myeloma: Immune Response May Predict Progression
    Before symptoms of multiple myeloma develop, Dana-Farber Cancer Institute researchers say a patient’s risk of progression might be tied to certain precursor conditions. The findings were presented at the American Society of Hematology Annual Meeting.

  • Breakthrough for Young Man Treated for Sickle Cell Disease
    An incredible breakthrough for a young man treated for sickle cell disease at the Dana-Farber/Boston Children’s Cancer and Blood Disorder Center. Doctors announce first success story from a new gene therapy strategy.

  • Ovarian Cancer: Past, Present, Future
    Patients diagnosed 34 years apart share their journey with ovarian cancer - reflecting on advances, similarities, and work that still needs to be done. They're brought together by their efforts for Dana-Farber's Susan F. Smith Center for Women's Cancers Executive Council.

  • Metastatic HPV-linked Head and Neck Cancer Study
    Study findings in metastatic HPV-linked head and neck cancer may help guide treatment. Findings published in JCI Insight show better survival rates for some patients. After analyzing tumor DNA, they found these patients have certain mutations in a particular pathway.

  • Boston News Reporter Opens Up About Breast Cancer
    Boston-based television reporter Kelli O'Hara opens up about her journey with breast cancer, the challenges she's facing as a younger woman balancing career and treatment, and her desire to one day have a family.

  • The Metastatic Prostate Cancer Project - Giving a Voice to Prostate Cancer Patients
    “Count Me In” is a new nonprofit organization aiming to partner patients directly with researchers for a number of cancers, including metastatic prostate cancer. For prostate cancer patients, it’s a way to give a voice to a disease that men typically don’t like to talk about. To learn more:

  • Chemical Biology: Small Molecules Making a Big Impact
    A look inside the growing Chemical Biology program at Dana-Farber Cancer Institute. Program Director Dr. Milka Kostic takes you into the labs where chemists and biologists work side-by-side, making and testing small molecules. They're seeking out what might be driving a cancer tumor and the hope is, these molecules might someday be powerful cancer-fighting drugs.

  • Chemotherapy or No Chemotherapy in Breast Cancer
    New findings announced this year show many women with the most common type of breast cancer can confidently skip chemotherapy. Dr. Eric Winer, chief of Dana-Farber Cancer Institute's Breast Oncology Treatment Center, breaks down what women need to know.

  • Rare Genitourinary Cancer
    Imagine having a cancer so rare, trials don't exist for you. That's been the case for years for patients with certain genitourinary cancers. Now, a first of its kind trial at Dana-Farber Cancer Institute offers a potential turning point and the opportunity to try a promising therapy.

  • Coding for Cancer
    Forget Silicon Valley, these women chose Dana-Farber Cancer Institute, working with some of the top minds in cancer genomics. Oncologists and computational biologists come together to analyze sequenced tumors in the hopes of matching tumors with targeted therapies.

  • Study Aims to Help Breast Cancer Patients Emotionally Recover
    Cancer survivors know the journey doesn’t end when treatment ends. That’s especially true for young breast cancer survivors, who often report feeling isolated and anxious. Doctors at Dana-Farber Cancer Institute are looking at mindfulness meditation and survivorship education as part of the "Pathways to Wellness" study.

  • Diet Linked to Bacteria and Certain Types of Colorectal Cancer
    Dana-Farber Cancer Institute researchers looked at the link between diet, gut-health, and colorectal cancers. They found the risk of certain cancers went up if people were eating diets high in red and processed meat, refined grains, and sugar. The study was published in the October 2018 issue of "Clinical Gastroenterology and Hepatology."

  • New Guidelines for Colorectal Cancer Screening
    Dana-Farber Cancer Institute's Dr. Jeffrey Meyerhardt explains why "45" is the new important age when it comes to getting screened for colorectal cancer.

  • 60-year-old Medical Mystery Surrounding Thalidomide Solved
    More than 60 years after the drug thalidomide caused birth defects in thousands of children whose mothers took the drug while pregnant, scientists at Dana-Farber Cancer Institute have solved a mystery that has lingered ever since the dangers of the drug first became apparent: how did the drug produce such severe fetal harm?

  • Cameron Smith Returns to Dana-Farber
    Forty years after being treated for pediatric cancer, Cameron Smith returned to Dana-Farber in an emotional homecoming, and shared a message of hope. Victoria Warren reports for Dana-Farber Cancer Institute.

  • Request a Publication

    Receive by mail the current issue of a Dana-Farber publication by completing this request form.

  • Dana-Farber Facts 2018

    Dana-Farber Facts

    Find facts, figures, and useful information about Dana-Farber's operations and services, including statistics about outpatient visits, clinical trials, patient volume, financial results, and much more.